Inicio>>Signaling Pathways>> DNA Damage/DNA Repair>> Eukaryotic Initiation Factor (eIF)>>(Z)-4EGI-1

(Z)-4EGI-1

Catalog No.GC39842

(Z)-4EGI-1 es el isÓmero Z de 4EGI-1 y es un inhibidor de la interacciÓn eIF4E/eIF4G y del inicio de la traducciÓn. (Z)-4EGI-1 se une eficazmente a eIF4E con una IC50 de 43,5 μM y un valor de Kd de 8,74 μM. (Z)-4EGI-1 tiene actividad anticancerÍgena.

Products are for research use only. Not for human use. We do not sell to patients.

(Z)-4EGI-1 Chemical Structure

Cas No.: 901787-88-0

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
255,00 $
Disponible
5mg
232,00 $
Disponible
10mg
352,00 $
Disponible
50mg
881,00 $
Disponible
100mg
1.344,00 $
Disponible
250mg
2.039,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(Z)-4EGI-1 is the Z-isomer of 4EGI-1 and is an inhibitor of eIF4E/eIF4G interaction and of translation initiation. (Z)-4EGI-1 effectively binds to eIF4E with an IC50 of 43.5 μM and a Kd value of 8.74 μM. (Z)-4EGI-1 has anticancer activity[1][2].

[1]. Khuloud Takrouri, et al. Structure-activity Relationship Study of 4EGI-1, Small Molecule eIF4E/eIF4G Protein-Protein Interaction Inhibitors. Eur J Med Chem. 2014 Apr 22;77:361-77. [2]. Poornachandran Mahalingam, et al. Synthesis of Rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) Mimetic and Their in Vitro Characterization as Inhibitors of Protein-Protein Interaction. J Med Chem. 2014 Jun 26;57(12):5094-111.

Reseñas

Review for (Z)-4EGI-1

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (Z)-4EGI-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.